Dangers and Opportunities of Direct-to-Consumer Advertising

J Gen Intern Med. 2018 May;33(5):586-587. doi: 10.1007/s11606-018-4342-9.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Advertising
  • Direct-to-Consumer Advertising*
  • Drug Industry
  • Humans
  • Off-Label Use
  • United States
  • United States Food and Drug Administration